Insider · CIK 0002022547
Paul Josephs
Files at LFCR (LIFECORE BIOMEDICAL, INC. \DE\). First filing Jan 8, 2025, latest Jan 8, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LFCR: LIFECORE BIOMEDICAL, INC. \DE\
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | LFCRbuy LIFECORE BIOMEDICAL, INC. \DE\ | $98k 17,000 shares | +3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | MOption exercise Common Stock | +150,000 | - | - | 688,185 | Jul 10, 2025 |
| Jul 8, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | FTax withholding Common Stock | -54,857 | $8.19 | $449k | 633,328 | Jul 10, 2025 |
| Jul 8, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | MOption exercise Performance-Based Restricted Stock Unitsderivative | -150,000 | - | - | 1,350,000 | Jul 10, 2025 |
| May 20, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | FTax withholding Common Stock | -21,532 | $6.63 | $143k | 538,185 | May 22, 2025 |
| Jan 8, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | POpen-market purchase Common Stock | +17,000 | $5.74 | $98k | 559,717 | Jan 8, 2025 |
| Dec 6, 2024 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | AGrant or award Common Stock | +38,461 | $0.00 | $0 | 554,486 | Dec 10, 2024 |
| Dec 6, 2024 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | FTax withholding Common Stock | -11,769 | $7.15 | $84k | 542,717 | Dec 10, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.